Icon

Rayos - (1, 2, 5 mg; Tablet, Delayed Release)

Prednisone Horizon Pharma
1, 2, 5 mg; Tablet, Delayed Release
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
None
Less Than 5
None
RAYOS is a corticosteroid indicated • as an anti-inflammatory or immunosuppressive agent for certain allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, specific infectious diseases or conditions and organ transplantation • for the treatment of certain endocrine conditions • for palliation of certain neoplastic conditions
Yes
******* ** *** ***** ** **** **** ** **** ******* '***- *** **, ****; '***- *** **, ****; '***- *** **, **** ; '***- *** ** *** '***- *** **, **** *** *** ************ *********. ******* *** ********** *** ***** ******* **** *******, ********* ** *** ***** ** ***** ******* *** ****** *** ******* ** *** **, ****. ******* *** **** ***** * **** ** **** *** **** ******* *** *** ********* *** *** ** ******* *** ***** *** ******** *** **** *** ***** *** ********** **** *** *** *********.
Rayos Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6
******* ******* ******* ******* ******* ******* *******
*** ****** **** ********* **** ********* **** ********* **** ********* **** ********* **** *********
** *****'* *** ********* *** ********* *** ********* *** ********* *** ********* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** **, **** ******* ******** *** ****** *******
*** ****** ** \ ** ***** **, **** **** ********* **** *** ** ******
** *****'* ** \ ** *** **, **** ******* **** ******* *** **** *** *** ****
  1. *** **, **** : ******* ******** ******* ****** ***** *** **** ** **** ******* '***- *** **, ****; '***- *** **, ****; '***- *** **, **** ; '***- *** ** *** '***- *** **, ****
  2. *** **, **** : ******* ***** * **** ******* ******* ** ******** ***** ** **.
  3. *** **, **** : ******* ***** * **** ******* *** ** *** ***** **** ** **** ******* '***- *** **, ****; '***- *** **, ****; '***- *** **, **** ; '***- *** ** *** '***- *** **, ****.
  4. *** **, **** : *** ******** *** **** *** ***** *** **** *** ********** **** *** *** *********.
  5. *** *, **** : ******* *** ******* ******* * **********, ********* ** *** ***** ** ***** ******* *** ****** *** ******* ** *** **, ****.
  6. *** **, **** : ** *****'* ******** ******* ** ***** **** ** ****** **** ****** '*** (*** *, ****).
  7. *** *, **** : ******* **** ** *****'* **** ************ ** ****** '*** (*** *, ****).
  8. *** **, **** : ******* *** ** *****'* **** ******* ********* **********. ** ****** ** ** * **********.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.